<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02029820</url>
  </required_header>
  <id_info>
    <org_study_id>11/05339</org_study_id>
    <nct_id>NCT02029820</nct_id>
  </id_info>
  <brief_title>RenalGuard System for Prevention of Contrast Induced Nephropathy</brief_title>
  <acronym>REPRECIN</acronym>
  <official_title>RenalGuard System for Prevention of Contrast Induced Nephropathy - A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Sao Lucas da PUCRS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Sao Lucas da PUCRS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether hydration with intravenous saline matched
      with urine output, using the device RenalGuard is superior to standard hydration with saline
      to prevent contrast-induced nephropathy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of contrast-induced nephropathy</measure>
    <time_frame>72 hours</time_frame>
    <description>Contrast-induced nephropathy defined as an increase of serum creatinine of 0.5mg/dl or 25% in pre procedure serum creatinine at 72h after procedure</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Radiographic Contrast Agent Nephropathy</condition>
  <arm_group>
    <arm_group_label>RenalGuard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hydration with the device renalguard</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Hydration with saline 1ml/Kg/h for 12h</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RenalGuard</intervention_name>
    <description>Intravenous saline hydration matched with urine output, using the device Renalguard</description>
    <arm_group_label>RenalGuard</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  serum creatinine &gt;1.2mg/dl

          -  glomerular filtration rate (GFR) &lt; 60ml/min

        Exclusion Criteria:

          -  acute renal failure

          -  use of radiological contrast in the latest 7 days

          -  Current use of N-acetylcysteine or hydration of sodium bicarbonate

          -  Patients in dialysis

          -  Emergency procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vitor O Gomes, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Sao Lucas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aryadina Piva, RN</last_name>
    <phone>55 51 33203494</phone>
    <email>pesquisa@cardiarte.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital São Lucas -PUCRS, Serviço de Hemodinâmica</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90610-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aryadina Piva, RN</last_name>
      <phone>55 51 3320 3494</phone>
      <email>pesquisa@cardiarte.com.br</email>
    </contact>
    <investigator>
      <last_name>Vitor O Gomes, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2014</study_first_submitted>
  <study_first_submitted_qc>January 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2014</study_first_posted>
  <last_update_submitted>January 6, 2014</last_update_submitted>
  <last_update_submitted_qc>January 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Sao Lucas da PUCRS</investigator_affiliation>
    <investigator_full_name>Vitor Osorio Gomes</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Contrast Nephropathy</keyword>
  <keyword>Prevention</keyword>
  <keyword>Renalguard</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

